Ten individuals, including five pharmaceutical distributor executives and five sales representatives and brokers, have been charged by the Department of Justice in connection with the unlawful distribution of nearly 70 million opioid pills and over 30 million doses of commonly…

Novo Nordisk plans to invest approximately $158 million into revamping its Montes Claros manufacturing facility in Minas Gerais, Brazil, Bloomberg reported Oct. 5. 

Kroger Co. has finalized the sale of its speciality pharmacy business to Elevance Health, according to an Oct. 4 news release. 

After Baxter International temporarily closed its North Cove facility in Marion, N.C., the company told customers in an Oct. 3 email to evaluate their inventory of several saline, dextrose and Lactated Ringer's presentations. 

The shortage of tirzepatide injection has been resolved after two years of limited availability in the wake of high demand, the FDA said. 

The second cycle of the Medicare Drug Price Negotiation Program will offer pharma companies more time and chances to submit counteroffers during the price talks, which will take place throughout 2025. 

Regulatory officials and Alzheimer's researchers expressed concern over the efficacy of Alzheimer's drug simufilam, developed by Cassava Sciences, The New York Times reported Oct. 3. 

Eli Lilly is building a $4.5 billion facility in Indiana that will combine research and production, aiming to enhance manufacturing efficiency and accelerate the development of clinical trial medicines, the drugmaker said Oct. 2. 

On Oct. 1, Louisiana became the first state to classify mifepristone and misoprostol — drugs used in medication abortion — as controlled substances. 

CVS Health is contemplating a breakup of its diversified operations after a tumultuous financial period marked by repeated forecast cuts and a significant drop in stock value, The Wall Street Journal reported Oct. 1.